August Krogh Building
Copenhagen, Denmark
NCT Number: NCT04558190
The purpose of the study is to evaluate the link between insulin resistance and alterations in skeletal muscle mitochondrial redox homeostasis
Looking for future studies?
Notify Me40 year–60 year
Male
Interventional
Not applicable
Copenhagen, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lipid infusion
Oral administration of MitoQ capsules
Other names: Mitoquinone mesylate, Mitoquinone, MitoQ10
Beta2-agonist infusion
Time frame: 5 hours after lipid infusion
Whole body insulin sensitivity is determined by hyperinsulinemic isoglycemic clamp method
Time frame: 5 hours after lipid infusion
Insulin-dependent skeletal muscle glucose uptake is determined by hyperinsulinemic isoglycemic clamp method integrated with measurements of femoral artery blood flow and arteriovenous difference of glucose
Time frame: Baseline
Mitochondrial O2 flux is determined in skeletal muscle biopsies by high-resolution fluorespirometry
Time frame: Baseline
Mitochondrial H2O2 emission rate is determined in skeletal muscle biopsies by high-resolution fluorespirometry
Time frame: Before (baseline) as well as 3 and 5 hours after lipid infusion
Peroxiredoxin3 dimer/monomer ratio is determined in skeletal muscle biopsies
Time frame: Before (baseline) as well as 3 and 5 hours after lipid infusion
GSH/GSSG ratio is determined in skeletal muscle biopsies
Time frame: Before (baseline) as well as 3 and 5 hours after lipid infusion
Phosphorylation status of proteins modulating insulin action is determined in skeletal muscle biopsies
Time frame: Baseline
Pulmonary maximal oxygen uptake (VO2max) is determined during an incremental exercise test to exhaustion
Time frame: Baseline
Fat free mass and fat mass are determined by dual-energy X-ray absorptiometry (DXA)
University of Copenhagen
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01809288
Behavior, Body Weight
Bethesda, Maryland, United States
View Trial DetailsNCT00340132
Body Weight, Body Weight Changes
Phoenix, Arizona, United States
View Trial DetailsNCT07701005
Body Weight, Digestive System Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03627104
Body Weight, Glucose Metabolism Disorders
Mexico City, Mexico
View Trial Details